These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11926349)

  • 21. The economic burden of hypertension in rural south-west China.
    Le C; Zhankun S; Jun D; Keying Z
    Trop Med Int Health; 2012 Dec; 17(12):1544-51. PubMed ID: 22973901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healthcare Costs Attributable to Hypertension: Canadian Population-Based Cohort Study.
    Weaver CG; Clement FM; Campbell NR; James MT; Klarenbach SW; Hemmelgarn BR; Tonelli M; McBrien KA;
    Hypertension; 2015 Sep; 66(3):502-8. PubMed ID: 26169049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying the economic benefits of prevention in a healthcare setting with severe financial constraints: the case of hypertension control.
    Athanasakis K; Kyriopoulos II; Boubouchairopoulou N; Stergiou GS; Kyriopoulos J
    Clin Exp Hypertens; 2015; 37(5):375-80. PubMed ID: 25496288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
    Dunbar SB; Khavjou OA; Bakas T; Hunt G; Kirch RA; Leib AR; Morrison RS; Poehler DC; Roger VL; Whitsel LP;
    Circulation; 2018 May; 137(19):e558-e577. PubMed ID: 29632217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High blood pressure in Latin America: a call to action.
    Rubinstein A; Alcocer L; Chagas A
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):259-85. PubMed ID: 19561117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The burden and correlates of hypertension in rural Ghana: a cross-sectional study.
    Williams EA; Keenan KE; Ansong D; Simpson LM; Boakye I; Boaheng JM; Awuah D; Nkyi CA; Nyannor I; Arhin B; Alder S; Benson LS; Dickerson TT
    Diabetes Metab Syndr; 2013; 7(3):123-8. PubMed ID: 23953175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands.
    Boersma C; Carides GW; Atthobari J; Voors AA; Postma MJ
    Clin Ther; 2007 May; 29(5):963-971. PubMed ID: 17697915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model.
    Scholze J; Alegria E; Ferri C; Langham S; Stevens W; Jeffries D; Uhl-Hochgraeber K
    BMC Public Health; 2010 Sep; 10():529. PubMed ID: 20813031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparisons of hypertension-related costs from multinational clinical studies.
    Mullins CD; Sikirica M; Seneviratne V; Ahn J; Akhras KS
    Pharmacoeconomics; 2004; 22(15):1001-14. PubMed ID: 15449964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.
    Wolf-Maier K; Cooper RS; Banegas JR; Giampaoli S; Hense HW; Joffres M; Kastarinen M; Poulter N; Primatesta P; Rodríguez-Artalejo F; Stegmayr B; Thamm M; Tuomilehto J; Vanuzzo D; Vescio F
    JAMA; 2003 May; 289(18):2363-9. PubMed ID: 12746359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The burden of smoking-related diseases in Brazil: mortality, morbidity and costs.
    Pinto MT; Pichon-Riviere A; Bardach A
    Cad Saude Publica; 2015 Jun; 31(6):1283-97. PubMed ID: 26200375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH).
    Naser N; Dzubur A; Durak A; Kulic M; Naser N
    Med Arch; 2016 Jul; 70(4):274-279. PubMed ID: 27703288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review.
    Gheorghe A; Griffiths U; Murphy A; Legido-Quigley H; Lamptey P; Perel P
    BMC Public Health; 2018 Aug; 18(1):975. PubMed ID: 30081871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The economic burden of chronic cardiovascular disease for major insurers.
    Trogdon JG; Finkelstein EA; Nwaise IA; Tangka FK; Orenstein D
    Health Promot Pract; 2007 Jul; 8(3):234-42. PubMed ID: 17606951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Swedish cost burden of overweight and obesity--evaluated with the PAR approach and a statistical modelling approach.
    Odegaard K; Borg S; Persson U; Svensson M
    Int J Pediatr Obes; 2008; 3 Suppl 1():51-7. PubMed ID: 18278633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct cost of systemic arterial hypertension and its complications in the circulatory system from the perspective of the Brazilian public health system in 2019.
    Curado DDSP; Gomes DF; Silva TBC; Almeida PHRF; Tavares NUL; Areda CA; da Silva EN
    PLoS One; 2021; 16(6):e0253063. PubMed ID: 34111216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing cardiovascular disease among Canadians: what are the potential benefits of treating hypertension or dyslipidemia?
    Grover SA; Coupal L; Kaouache M; Lowensteyn I
    Can J Cardiol; 2007 May; 23(6):467-73. PubMed ID: 17487292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the cost of epilepsy in Europe: a review with economic modeling.
    Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
    Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.